Skip to content
10-K

Annual Report

CVS HEALTH Corp CVS

0000064803-25-000007

← back to feed
Filed
Feb 12, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 5, 2025 1.26B sh
Short Term Debt FY 2024 · Dec 31, 2023 $200M
Short Term Investments FY 2024 · Dec 31, 2023 $3.26B
Stockholders Equity FY 2024 · Dec 31, 2023 $76.46B
Current Liabilities FY 2024 · Dec 31, 2023 $79.19B
Total Liabilities FY 2024 · Dec 31, 2023 $173.09B
Current Assets FY 2024 · Dec 31, 2023 $67.86B
Total Assets FY 2024 · Dec 31, 2023 $249.73B
Shares Diluted FY 2024 · Dec 31, 2022 1.32B sh
Stock Repurchased FY 2024 · Dec 31, 2022 $3.5B
Dividends Paid FY 2024 · Dec 31, 2022 $2.91B
Capex FY 2024 · Dec 31, 2022 $2.73B
Operating Cash Flow FY 2024 · Dec 31, 2022 $16.18B
Cash And Equivalents FY 2024 · Dec 31, 2022 $12.95B
Eps Diluted restated FY 2024 · Dec 31, 2022 $3.26
Eps Basic restated FY 2024 · Dec 31, 2022 $3.29
Net Income restated FY 2024 · Dec 31, 2022 $4.31B
Operating Income restated FY 2024 · Dec 31, 2022 $7.95B